How to prepare your P&MA function for the future – current challenges and best-practice solutions

Published on February 27, 2023

Is your P&MA function future ready? The increasing complexity of products, intensified competition, evolution of payers’ needs, and stricter healthcare systems are some of the factors that have increased the need to check in on your P&MA function!

As we have followed this multifaceted evolution over the last few years, pricing and market access (P&MA) has shifted from a technical function to a strategic one within global, regional, and local organizations.

Looking to the future, companies need to be prepared for the ongoing and upcoming changes to the requirements for the P&MA function.

According to best-in-class examples, a successful P&MA function needs to excel in three dimensions: establishing an effective set-up (organization), doing the right things (operations), and having the required capabilities in place (talent management).

Key areas for a best-in-class P&MA function

…

Continue reading on website
Other news

China: Commercial health insurance trends

February 27, 2023
While the National Reimbursement Drug List (NRDL) continues to be the dominant path to public reimbursement in China, commercial health insurance (CHI) in China is quickly emerging as an alternative reimbursement option. Its development gained momentum particularly around 2015, driven by government policy support, unmet demand, and supply-side innovations.City CHI has been one of the fastest-growi

2023 China Medtech Industry Outlook

February 27, 2023
Building on ongoing in-depth discussions with leaders in the medtech industry, our 2023 China Medtech Outlook is now out, with key themes highlighted in the article below.  Policy drivers: The positives and negatives In September 2022, China unveiled a subsidized loan scheme amounting to 200 billion yuan (RMB) for hospitals to build up their hardware. This bodes well for medtech companies, especia